Additionally, modulation of AhR by other microbial metabolites, such as quinolinic acid, has been shown to regulate inflammatory pathways such as the NLR family pyrin domain-containing 3 inflammasome, further supporting the potential of targeting AhR in AD treatment [79]. The gene discussed is AHR; the disease is Alzheimer disease.